Novartis India Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Novartis India will hold a meeting of the Board of Directors of the Company on 23 July 2026.

Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 12 May 2026.

Novartis India announced that Sandra Martyres (DIN: 00798406), Independent Director, shall be completing her second and final term as an Independent Director of the Company on 18 April 2026. Accordingly, she ceases to be the Director of the Company w.e.f. close of business hours of 18 April 2026.

Powered by Capital Market - Live News